December 2010
Trial watch: Targeting IL-17A shows broad promise in autoimmune diseases

December 2010
Therapy: Anti-inflammatory hope for AIN457
by Emma Leah

November/December 2010
2011 Year in Preview: Enhancing the Pipeline
by PharmaVoice

November 16, 2010
A Turnaround for Toxicogenomics
by Dora Farkas - BIO-IT World

November 16, 2010
Novel IT Platform Helps Novartis Gain Control of Clinical Imaging Data
by Kevin Davies, Bio-IT World

November 14, 2010
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
by Zainab Jagani et al

November 11, 2010
Circuitry of fear identified
by Friedrich Miescher Institute for Biomedical Research (FMI)

November 8, 2010
Look out your medicine is watching you
by Ben Hirschler, Reuters

November 2010
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
by Nature Reviews

November 2010
Antimalarial drugs: Speeding to a new lead
by Man Tsuey Tse, Nature Reviews

October 27, 2010
Novartis doubles plan for Cambridge
by Casey Ross and Robert Weisman

October 18, 2010
Handing Down Hope - Novartis Exchange with Kenyatta University scientists
by Linda Wang

October 14, 2010
Smoothening Resistance
by Lev Osherovich

October 13, 2010
Cambridge's top 25 employers
by Wicked Local Cambridge

October 6, 2010
Reprint - Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
by Science Translational Medicine

October 6, 2010
Experimental Novartis Drug Helps Range of Diseases
by Kate Kelland

October 5, 2010
Novartis backed Genomics Institute Names Martin Seidel as Director
by Luke Timmerman

October 2010
China Booms: The new superpower
by By Ajeesh Anand - BioSpectrum Asia

September 29, 2010
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K in Medullablastoma
by Silvia Buonamici, et al.

September 2, 2010
Scientists Closer to Malaria Cure
By Felix Greaves

August 2010
Firms combine experimental cancer drugs to speed development
by Cormac Sheridan

August 4, 2010
Newly Formed Commission Wants Cambridge's Central Square to be 'More Vital'
by Jen Thomas

July 30, 2010
Get Moving: How Exercise can Alleviate Fibromyalgia Pain
by Suzanne Levy

July 25, 2010
The Power of Cancer Genome Sequencing
by Rabiya S. Tuma

June 7, 2010
Research Recalibrated
by Lisa M. Jarvis

May 20, 2010
DIVERSITYINC: Top 10 Companies for Global Diversity
by Barbara Frankel

May 20, 2010
Ghanaian Pharmacist to Roll out new Cancer Drug
by Ghana News Agency

May 17, 2010
For Novartis Cambridge is a Growth Site
by Robert Weisman

May 3, 2010
Big Pharma Comes To Town
When in Cambridge, major drug companies play by Cambridge rules in a quest for breakthroughs
By Rick Mullin

May 3, 2010
Novartis Postdoc Program Takes An Academic Track
Researchers gaining exposure to industrial science are encouraged to publish
By Rick Mullin

April 30, 2010
Promise Seen in Drug for Retardation Syndrome
By Gardiner Harris

April 13, 2010
Novartis moves closer to first oral MS treatment
by Katie Reid

March 25, 2010
Novartis Beats Rush Hour with Flex-Hours
By Christine Cignoli, Special to Mass High Tech

March 15, 2010
Outwitting germs that never say die - Persister cells baffle, intrigue researchers
By Carolyn Y. Johnson - Boston Globe Staff

March 8, 2010
Town Hall Meeting Predicts Chemistry's Future
By Amanda T. Yarnell - ACS News

February 2, 2010
AUC Graduate Student Creates Advanced Device for Allergy Testing
AUC Now

January 2010
NIBR Touts Promising Drugs, Lab of Future
By Christiane Truelove, PharmaLive